Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Actuate Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 43 | 45 | +2 |
| Shares | 12.0M | 13.1M | +1.08M (+9.0%) |
| Value | $80.5M | $80.2M | −$221.3K (−0.3%) |
New holders (8)
Institutions that held Actuate Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 94,592 | $578.9K | 0.03% |
| Bridgeway Capital Management, LLC | 30,982 | $189.6K | 0.00% |
| Rock Creek Group, LP | 21,759 | $133.2K | 0.01% |
| Jane Street Group, LLC | 16,625 | $101.7K | 0.00% |
| Bank of New York Mellon Corp | 12,565 | $76.9K | 0.00% |
| Susquehanna International Group, LLP | 10,253 | $62.7K | 0.00% |
| ABS Direct Equity Fund LLC | 6,597 | $40.4K | 0.05% |
| True Wealth Design, LLC | 1 | $7 | 0.00% |
Sold out (6)
Institutions that held Actuate Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Freestone Capital Holdings, LLC | 10,000 | $66.9K |
| Northwestern University | 6,488 | $43.4K |
| Wealthspire Advisors, LLC | 5,000 | $33.5K |
| Prosight Management, LP | 885 | $5.92K |
| The PNC Financial Services Group, Inc. | 384 | $2.57K |
| SRS Capital Advisors, Inc. | 60 | $401 |